The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in the LCD. N0: no regional lymph node metastasis. Per the 2020 ICD-10 guidelines, 'consistent with' should be treated as an uncertain diagnosis, wh [QUOTE="TThivierge, post: 478222, member: 216725"] End Users do not act for or on behalf of the CMS. Contractors may specify Bill Types to help providers identify those Bill Types typically
You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. Sometimes, a large group can make scrolling thru a document unwieldy. If your session expires, you will lose all items in your basket and any active searches. All neoplasms are classified in this chapter, whether they are functionally active or not. (ajcc 6th and 7th eds.). As used herein, "you" and "your" refer to you and any organization on behalf of which you are acting. Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material. Lady T:cool: [QUOTE="jh1991, post: 469112, member: 237375"] COMPREHENSIVE ICD-10-CM Casefinding Code List for Reportable Tumors EFFECTIVE: 01/01/2021 . Applications are available at the American Dental Association web site. C44.02 Squamous cell carcinoma of skin of lip C44.12- Squamous cell carcinoma of skin of eyelid, including canthus End Users do not act for or on behalf of the CMS. All neoplasms are classified in this chapter, whether they are functionally active or not. Please review and accept the agreements in order to view Medicare Coverage documents, which may include licensed information and codes. C44.22- Squamous cell carcinoma of skin of ear and external auricular canal Curettage and electrodessication (C and E). The code lists in the article help explain which services (procedures) the related LCD applies to, the diagnosis codes for which the service is covered, or for which the service is not considered reasonable and necessary and therefore not covered. Please enable "JavaScript" and revisit this page or proceed with browsing CMS.gov with
article does not apply to that Bill Type. If you do not agree with all terms and conditions set forth herein, click below on the button labeled "I do not accept" and exit from this computer screen. (based on ajcc cancer staging). C44.82 Squamous cell carcinoma of overlapping sites of skin The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11620, 11621, 11622, 11623, 11624, and 11626. 2. Treatment can involve surgical and nonsurgical methods. All Rights Reserved (or such other date of publication of CPT). CPT codes, descriptions and other data only are copyright 2022 American Medical Association. ICDO3 codes, behaviors and terms are sitespecific Updated 8/22/2018 Numeric Order by Morphology Code Status ICDO3 Morphology Code Term Reportable Y/N Comments New Term 8010/3 Urachal carcinoma (C65.9, C66.9, C67. Neither the United States Government nor its employees represent that use of such information, product, or processes
Federal government websites often end in .gov or .mil. Compliance with the provisions in LCD L33813, Destruction of Malignant Skin Lesions may be monitored and addressed through post payment data analysis and subsequent medical review audits. Bowen's disease: squamous cell carcinoma in situ Bowen's disease is a premalignant condition that clinically presents as an asymptomatic, scaly or crusted plaque on the skin. Applicable FARS\DFARS Restrictions Apply to Government Use. Reproduced with permission. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not
Objectives: To determine patient and disease characteristics, treatment patterns and long-term outcomes, in order to help direct management of patients with VIN 3, to examine the risk of development of cancer following a diagnosis of VIN 3 and the risk of recurrent disease requiring multiple treatment episodes, and to review patients with vulval cancer, in order to establish the relative . on Squamous Cell Carcinoma ICD-10-CM Coding, Tech & Innovation in Healthcare eNewsletter, Excision of Benign or Malignant Skin Lesion, Healthcare Finance Newsday: "AHIMA, AHA back move to ICD-10 as other groups cite high costs", AAPC to Host 17th Annual National Conference in Las Vegas in April 2009, Portability Issues Give PHRs a Rocky Start, Dome-shaped or crusty lesion that may bleed, Flat, reddish, scaly patch that grows slowly, Blue or green eyed people with blond or red hair, Long-term daily sun exposure, as with people that work outdoors with no sun protection or covering up, Older age. Instructions for enabling "JavaScript" can be found here. You are leaving the CMS MCD and are being redirected to the CMS MCD Archive that contains outdated (No Longer In Effect) Local Coverage Determinations and Articles, You are leaving the CMS MCD and are being redirected to, Billing and Coding: Destruction of Malignant Skin Lesions, AMA CPT / ADA CDT / AHA NUBC Copyright Statement, Article - Billing and Coding: Destruction of Malignant Skin Lesions (A57638). Applicable FARS\DFARS Restrictions Apply to Government Use. The submitted medical record must support the use of the selected ICD-10-CM code(s). An asterisk (*) indicates a
Therefore, if a drug is self-administered by more than 50 percent of Medicare beneficiaries, the drug is excluded from coverage" and the MAC will make no payment for the drug. All documentation must be maintained in the patient's medical record and made available to the contractor upon request. Skin []. The submitted medical record must support the use of the selected ICD-10-CM code(s). Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11620, 11621, 11622, 11623, 11624, and 11626. "JavaScript" disabled. HPV-related oropharyngeal squamous cell carcinoma (OPSCC) is associated with a favorable prognosis, yet patients of color and low socioeconomic status (SES) continue to experience inferior outcomes. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. Signs and symptoms of SCCs include: Squamous cell carcinoma is most commonly seen in fair-skinned people who have spent extended time in the sun. CMS and its products and services are not endorsed by the AHA or any of its affiliates. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. It begins in the squamous cells, which comprise most of the skins epidermis. The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient. All rights reserved. Whether the site is primary, secondary, or carcinoma, Site on the skin (e.g., trunk, upper limb, or lower limb). Some articles contain a large number of codes. resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions;
THE UNITED STATES
You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. can we bill dx M54.42 and M51.16 together? of the Medicare program. As a contributor you will produce quality content for the business of healthcare, taking the Knowledge Center forward with your knowhow and expertise. See note under "HIST" variable. an effective method to share Articles that Medicare contractors develop. Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). Before sharing sensitive information, make sure you're on a federal government site. CMS and its products and services are not endorsed by the AHA or any of its affiliates. When billing for non-covered services, use the appropriate modifier. My provider is documenting a squamous cell carcinoma in situ of the jaw, do I code this as C44.329 or D04.39 as the SCC and in situ are separate ICD-10 codes? Article document IDs begin with the letter "A" (e.g., A12345). This section shows you chapter-specific coding guidelines to increase your understanding and correct usage of the target ICD-10-CM Volume 1 code. To submit a comment or question to CMS, please use the Feedback/Ask a Question link available at the bottom
The Table of Neoplasms should be used to identify the correct topography code. A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. If your session expires, you will lose all items in your basket and any active searches. Use is limited to use in Medicare, Medicaid or other programs administered by the Centers for Medicare and Medicaid Services (CMS). 0
You can use the Contents side panel to help navigate the various sections. For example, 173.22:Squamous cell carcinoma of the skin of the ear and external auditory canal. You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. Solar ultraviolet radiation (UVR) is the most significant occupational carcinogenic exposure in terms of the number of workers exposed (i.e., outdoor workers). damages arising out of the use of such information, product, or process. An official website of the United States government. The 2023 edition of ICD-10-CM D04.9 became effective on October 1, 2022. A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. The Medicare program provides limited benefits for outpatient prescription drugs. In men, lung . Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (, malignant neoplasm of skin of genital organs (, Primary malignant neoplasm of skin of left shoulder, Primary malignant neoplasm of skin of left upper limb. Cutaneous SCC is an invasive disease, referring to cancer cells that have grown beyond the epidermis. The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in the LCD. This Agreement will terminate upon notice if you violate its terms. By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood and agreed to all terms and conditions set forth in this agreement. B5l2`4'l2_v n6M#~zx#d[mp1VXlu[1NWJu~@}Z~@R'h&\x$f$e"
=ih9L|-U*|=LeXOs9"eY9j=IYRh{p "AYqn[sNxD!D>* Hqq0.DzXCX|P| VGi] kb$+%=IpzpTkk*. Subscribe to Codify by AAPC and get the code details in a flash. Example 1: A patient returns to the dermatologist to discuss removal of his SCC on his lower lip. Please visit the. The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare,
635 0 obj
<>stream
If the "INDICATOR" is set to "1" additional codes from ICD-O-3 code book were used. You can collapse such groups by clicking on the group header to make navigation easier. without the written consent of the AHA. "JavaScript" disabled. This systematic review is registered in PROSPERO (CRD42021295221) and aims to assess the . C34 Malignant neoplasm of the bronchi and lung. Noninvasive can be used as a synonym for in situ, ICD-O-3 behavior code /2. an effective method to share Articles that Medicare contractors develop. The medical record/progress note should indicate the removal of a malignant lesion with a corresponding pathology report or a clinical description consistent with a skin malignancy. If you are a particularly observant medical coder you8217ve probably noticed that many codes identified as deleted were actually promoted to new roles. Tanning bed use. Squamous cell carcinoma, skin of left breast; Squamous cell carcinoma, skin of right breast; ICD-10-CM C44.521 is grouped within Diagnostic Related Group(s) (MS-DRG v 40.0): 606 Minor skin disorders with mcc; 607 Minor skin disorders without mcc; Convert C44.521 to ICD-9-CM. complete information, CMS does not guarantee that there are no errors in the information displayed on this web site. The 4.2 cm excised diameter lesion Margins negative for You are correct - per Paget's, if it's a skin biopsy, it has to be a 305 no matter the size or number of cassettes (I have included the Paget's rule below). recipient email address(es) you enter. Basal cell carcinoma of skin of nose. If malignant, any secondary (metastatic) sites should also be . Check out the dx block of D04.4. C44.02 Squamous cell carcinoma of skin of lip Please do not use this feature to contact CMS. An ambiguous, but moderate to high suspicion lesion would be excised with moderate to wide surrounding grossly normal skin/soft tissue margins, as for a malignant lesion. There are 90 terms under the parent term 'Carcinoma In Situ' in the ICD-10-CM Alphabetical Index . The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 17260, 17261, 17262, 17263, 17264, 17266, 17270, 17271, 17272, 17273, 17274, 17276, 17280, 17281, 17282, 17283, 17284, 17286. This common malignancy is primarily seen in older adults and most frequently occurs on sun-exposed skin. Instructions for enabling "JavaScript" can be found here. Another option is to use the Download button at the top right of the document view pages (for certain document types). Morphology & Grade. malignant, in situ, benign, etc. However, services performed for any given diagnosis must meet all of the indications and limitations stated in the LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules. Bowen's disease, which is also called 'squamous cell carcinoma in situ' (SCC in situ), is a form of skin cancer. Conjunctival squamous cell carcinoma (conjunctival SCC) and corneal intraepithelial neoplasia comprise what are called ocular surface squamous cell neoplasias. D04.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. In this context, annotation back-references refer to codes that contain: This is the American ICD-10-CM version of. Carcinoma in situ of the cervix (CIN III-8077/2) and Prostatic Intraepithelial Carcinoma (PIN III-8148/2) are not reportable. and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only
Laser therapy. Medicare contractors are required to develop and disseminate Articles. Applications are available at the American Dental Association web site. THE UNITED STATES
. These abnormal cells may become cancer and spread into nearby normal tissue. 604 0 obj
<>
endobj
I hope this helps you. Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. article does not apply to that Bill Type. ICD 10. _, C68. For example, there is no way in ICD to distinguish between an adenocarcinoma of the lung and a squamous cell carcinoma of the lung: both would be coded to C34.9. 9: Squamous cell carcinoma of the anus, NOS Squamous cell carcinoma of the anus (C210) is reportable. For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. Neither the United States Government nor its employees represent that use of such information, product, or processes
This page displays your requested Article. Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Carcinoma In Situ ICD-10-CM Alphabetical Index The ICD-10-CM Alphabetical Index is designed to allow medical coders to look up various medical terms and connect them with the appropriate ICD codes. The 2023 edition of ICD-10-CM C44.52 became effective on October 1, 2022. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33818 - Excision of Malignant Skin Lesions, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER OVER 4.0 CM, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Unspecified malignant neoplasm of anal skin, Unspecified malignant neoplasm of skin of breast, Unspecified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder, Unspecified malignant neoplasm of skin of right upper limb, including shoulder, Unspecified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of unspecified upper limb, including shoulder, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of unspecified upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Unspecified malignant neoplasm of skin of unspecified lower limb, including hip, Unspecified malignant neoplasm of skin of right lower limb, including hip, Unspecified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of skin of unspecified lower limb, including hip, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of unspecified lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of unspecified lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Unspecified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Malignant neoplasm of overlapping sites of vulva, Malignant neoplasm of other specified female genital organs, Malignant neoplasm of overlapping sites of female genital organs, Malignant neoplasm of overlapping sites of penis, Malignant neoplasm of head, face and neck, Secondary malignant neoplasm of genital organs, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of unspecified female genital organs, Carcinoma in situ of other female genital organs, Carcinoma in situ of unspecified male genital organs, Carcinoma in situ of other male genital organs, Malignant neoplasm of external lip, unspecified, Malignant neoplasm of upper lip, inner aspect, Malignant neoplasm of lower lip, inner aspect, Malignant neoplasm of lip, unspecified, inner aspect, Malignant neoplasm of commissure of lip, unspecified, Malignant neoplasm of overlapping sites of lip, Malignant neoplasm of dorsal surface of tongue, Malignant neoplasm of ventral surface of tongue, Malignant neoplasm of anterior two-thirds of tongue, part unspecified, Malignant neoplasm of overlapping sites of tongue, Malignant neoplasm of tongue, unspecified, Malignant neoplasm of anterior floor of mouth, Malignant neoplasm of lateral floor of mouth, Malignant neoplasm of overlapping sites of floor of mouth, Malignant neoplasm of floor of mouth, unspecified, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant neoplasm of submandibular gland, Malignant neoplasm of major salivary gland, unspecified, Malignant neoplasm of tonsillar pillar (anterior) (posterior), Malignant neoplasm of overlapping sites of tonsil, Malignant neoplasm of tonsil, unspecified, Malignant neoplasm of anterior surface of epiglottis, Malignant neoplasm of lateral wall of oropharynx, Malignant neoplasm of posterior wall of oropharynx, Malignant neoplasm of overlapping sites of oropharynx, Malignant neoplasm of oropharynx, unspecified, Malignant neoplasm of superior wall of nasopharynx, Malignant neoplasm of posterior wall of nasopharynx, Malignant neoplasm of lateral wall of nasopharynx, Malignant neoplasm of anterior wall of nasopharynx, Malignant neoplasm of overlapping sites of nasopharynx, Malignant neoplasm of nasopharynx, unspecified, Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect, Malignant neoplasm of posterior wall of hypopharynx, Malignant neoplasm of overlapping sites of hypopharynx, Malignant neoplasm of hypopharynx, unspecified, Malignant neoplasm of pharynx, unspecified, Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of overlapping sites, Unspecified malignant neoplasm of skin of lip, Other specified malignant neoplasm of skin of lip, Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus, Unspecified malignant neoplasm of skin of right upper eyelid, including canthus, Unspecified malignant neoplasm of skin of right lower eyelid, including canthus, Unspecified malignant neoplasm of skin of left upper eyelid, including canthus, Unspecified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of unspecified eyelid, including canthus, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of unspecified eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus, Sebaceous cell carcinoma of skin of right upper eyelid, including canthus, Sebaceous cell carcinoma of skin of right lower eyelid, including canthus, Sebaceous cell carcinoma of skin of left upper eyelid, including canthus, Sebaceous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of unspecified eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal, Unspecified malignant neoplasm of skin of right ear and external auricular canal, Unspecified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of unspecified ear and external auricular canal, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of unspecified ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of unspecified ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Unspecified malignant neoplasm of skin of unspecified part of face, Unspecified malignant neoplasm of skin of nose, Unspecified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of unspecified parts of face, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of unspecified parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of unspecified parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Unspecified malignant neoplasm of overlapping sites of skin, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Carcinoma in situ of oral cavity, unspecified site, Carcinoma in situ of labial mucosa and vermilion border, Carcinoma in situ of gingiva and edentulous alveolar ridge, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Some older versions have been archived.